Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JS']JSH-HCC Guidelines)

被引：103

作者：

Hasegawa, Kiyoshi ^{[1
]}

Takemura, Nobuyuki ^{[2
]}

Yamashita, Tatsuya ^{[3
]}

Watadani, Takeyuki ^{[4
]}

Kaibori, Masaki ^{[5
]}

Kubo, Shoji ^{[6
]}

Shimada, Mitsuo ^{[7
]}

Nagano, Hiroaki ^{[8
]}

Hatano, Etsuro ^{[9
]}

Aikata, Hiroshi ^{[10
]}

Iijima, Hiroko ^{[11
]}

Ueshima, Kazuomi ^{[12
]}

Ohkawa, Kazuyoshi ^{[13
]}

Genda, Takuya ^{[14
]}

Tsuchiya, Kaoru ^{[15
]}

Torimura, Takuji ^{[16
]}

Ikeda, Masafumi ^{[17
]}

Furuse, Junji ^{[18
]}

Akahane, Masaaki ^{[19
]}

Kobayashi, Satoshi ^{[20
]}

Sakurai, Hideyuki ^{[21
]}

Takeda, Atsuya ^{[22
]}

Murakami, Takamichi ^{[23
]}

Motosugi, Utaroh ^{[24
]}

Matsuyama, Yutaka ^{[25
]}

Kudo, Masatoshi ^{[12
]}

Tateishi, Ryosuke ^{[26
]}

机构：

[1] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan

[2] Natl Ctr Global Hlth & Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan

[3] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Japan

[4] Univ Tokyo, Grad Sch Med, Dept Radiol, Tokyo, Japan

[5] Kansai Med Univ, Hirakata Hosp, Dept Surg, Hirakata, Japan

[6] Osaka Metropolitan Univ, Dept Hepatobiliary Pancreat Surg, Grad Sch Med, Osaka, Japan

[7] Tokushima Univ Hosp, Dept Digest & Transplant Surg, Tokushima, Japan

[8] Yamaguchi Univ, Dept Gastroenterol Breast & Endocrine Surg, Grad Sch Med, Yamaguchi, Japan

[9] Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg & Transplantat, Kyoto, Japan

[10] Hiroshima Univ Hosp, Dept Med & Mol Sci, Hiroshima, Japan

[11] Hyogo Med Univ, Dept Internal Med, Div Gastroenterol & Hepatobiliary, Nishinomiya, Japan

[12] Kindai Univ, Dept Gastroenterol & Hepatol, Fac Med, Higashiosaka, Japan

[13] Osaka Int Canc Inst, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan

[14] Juntendo Univ, Dept Gastroenterol & Hepatol, Shizuoka Hosp, Izunokuni, Japan

[15] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Musashino, Japan

[16] Kurume Univ, Dept Med, Div Gastroenterol, Sch Med, Kurume, Japan

[17] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Japan

[18] Kanagawa Canc Ctr, Dept Gastroenterol, Yokohama, Japan

[19] Int Univ Hlth & Welf, Sch Med, Dept Radiol, Otawara, Japan

[20] Kanazawa Univ, Dept Quantum Med Technol, Grad Sch Med Sci, Kanazawa, Japan

[21] Univ Tsukuba, Dept Radiat Oncol, Fac Med, Tsukuba, Japan

[22] Ofuna Chuo Hosp, Radiat Oncol Ctr, Kamakura, Japan

[23] Kobe Univ, Dept Radiol, Grad Sch Med, Kobe, Hyogo, Japan

[24] Kofu Kyoritsu Hosp, Dept Diagnost Radiol, Kofu, Japan

[25] Univ Tokyo, Sch Publ Hlth, Grad Sch Med, Dept Biostat, Tokyo, Japan

[26] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan

来源：

HEPATOLOGY RESEARCH | 2023年 / 53卷 / 05期

基金：

日本学术振兴会;

关键词：

algorithm for surveillance and diagnosis; algorithm for systemic therapy; algorithm for treatment; clinical practice guidelines; hepatocellular carcinoma; LIVER RESECTION; SORAFENIB;

D O I：

10.1111/hepr.13892

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The fifth version of the Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence-based medicine and partly to the Grading of Recommendations Assessment, Development and Evaluation system, which was published in October 2021 in Japanese. In addition to surveillance-diagnostic and treatment algorithms, a new algorithm for systemic therapy has been created, as multiple drugs for hepatocellular carcinoma can be currently selected. Here, new or revised algorithms and evidence on which the recommendations are based are described.

引用

页码：383 / 390

页数：8

共 20 条

[1] Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Abou-Alfa, G. K.
Meyer, T.
Cheng, A. -L.
El-Khoueiry, A. B.
Rimassa, L.
Ryoo, B. -Y.
Cicin, I.
Merle, P.
Chen, Y. H.
Park, J. -W.
Blanc, J. -F.
Bolondi, L.
Klumpen, H. -J.
Chan, S. L.
Zagonel, V.
Pressiani, T.
Ryu, M. -H.
Venook, A. P.
Hessel, C.
Borgman-Hagey, A. E.
Schwab, G.
Kelley, R. K.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) : 54 - 63
[2] [Anonymous], 2010, Hepatol Res, V40 Suppl 1, P2, DOI 10.1111/j.1872-034X.2010.00650.x
[3] Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Bruix, Jordi
Qin, Shukui
Merle, Philippe
Granito, Alessandro
Huang, Yi-Hsiang
Bodoky, Gyrogy
Pracht, Marc
Yokosuka, Osamu
Rosmorduc, Olivier
Breder, Valeriy
Gerolami, Rene
Masi, Gianluca
Ross, Paul J.
Song, Tianqiang
Bronowicki, Jean-Pierre
Ollivier-Hourmand, Isabelle
Kudo, Masatoshi
Cheng, Ann-Lii
Llovet, Josep M.
Finn, Richard S.
LeBerre, Marie-Aude
Baumhauer, Annette
Meinhardt, Gerold
Han, Guohong
[J]. LANCET, 2017, 389 (10064) : 56 - 66
[4] Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Finn, Richard S.
Qin, Shukui
Ikeda, Masafumi
Galle, Peter R.
Ducreux, Michel
Kim, Tae-You
Kudo, Masatoshi
Breder, Valeriy
Merle, Philippe
Kaseb, Ahmed O.
Li, Daneng
Verret, Wendy
Xu, Derek-Zhen
Hernandez, Sairy
Liu, Juan
Huang, Chen
Mulla, Sohail
Wang, Yulei
Lim, Ho Yeong
Zhu, Andrew X.
Cheng, Ann-Lii
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20) : 1894 - 1905
[5] Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]
[6] Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JS']JSH-HCC guidelines) 2019 update
Kokudo, Norihiro
Takemura, Nobuyuki
Hasegawa, Kiyoshi
Takayama, Tadatoshi
Kubo, Shoji
Shimada, Mitsuo
Nagano, Hiroaki
Hatano, Etsuro
Izumi, Namiki
Kaneko, Shuichi
Kudo, Masatoshi
Iijima, Hiroko
Genda, Takuya
Tateishi, Ryosuke
Torimura, Takuji
Igaki, Hiroshi
Kobayashi, Satoshi
Sakurai, Hideyuki
Murakami, Takamichi
Watadani, Takeyuki
Matsuyama, Yutaka
[J]. HEPATOLOGY RESEARCH, 2019, 49 (10) : 1109 - 1113
[7] Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JS']JSH-HCC Guidelines)
Kokudo, Norihiro
Hasegawa, Kiyoshi
Akahane, Masaaki
Igaki, Hiroshi
Izumi, Namiki
Ichida, Takafumi
Uemoto, Shinji
Kaneko, Shuichi
Kawasaki, Seiji
Ku, Yonson
Kudo, Masatoshi
Kubo, Shoji
Takayama, Tadatoshi
Tateishi, Ryosuke
Fukuda, Takashi
Matsui, Osamu
Matsuyama, Yutaka
Murakami, Takamichi
Arii, Shigeki
Okazaki, Masatoshi
Makuuchi, Masatoshi
[J]. HEPATOLOGY RESEARCH, 2015, 45 (02) : 123 - 127
[8] Liver Resection for Hepatocellular Carcinoma Associated With Hepatic Vein Invasion: A Japanese Nationwide Survey
Kokudo, Takashi
Hasegawa, Kiyoshi
Matsuyama, Yutaka
Takayama, Tadatoshi
Izumi, Namiki
Kadoya, Masumi
Kudo, Masatoshi
Kubo, Shoji
Sakamoto, Michiie
Nakashima, Osamu
Kumada, Takashi
Kokudo, Norihiro
[J]. HEPATOLOGY, 2017, 66 (02) : 510 - 517
[9] Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion
Kokudo, Takashi
Hasegawa, Kiyoshi
Matsuyama, Yutaka
Takayama, Tadatoshi
Izumi, Namiki
Kadoya, Masumi
Kudo, Masatoshi
Ku, Yonson
Sakamoto, Michiie
Nakashima, Osamu
Kaneko, Shuichi
Kokudo, Norihiro
[J]. JOURNAL OF HEPATOLOGY, 2016, 65 (05) : 938 - 943
[10] A multicenter randomized controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF trial): Analysis of overall survival.
Kudo, Masatoshi
Hasegawa, Kiyoshi
Kawaguchi, Yoshikuni
Takayama, Tadatoshi
Izumi, Namiki
Yamanaka, Naoki
Shimada, Mitsuo
Inomata, Masahumi
Kaneko, Shuichi
Baba, Hideo
Koike, Kazuhiko
Omata, Masao
Makuuchi, Masatoshi
Matsuyama, Yutaka
Kokudo, Norihiro
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

← 1 2 →